News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
641,149 Results
Type
Article (38805)
Company Profile (129)
Press Release (602208)
Multimedia
Podcasts (145)
Webinars (18)
Section
Business (185375)
Career Advice (1890)
Deals (31518)
Drug Delivery (128)
Drug Development (70742)
Employer Resources (140)
FDA (15635)
Job Trends (13313)
News (311508)
Policy (30267)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2171)
Academic (2)
Accelerated approval (30)
Adcomms (20)
Allergies (144)
Alliances (48714)
ALS (157)
Alzheimer's disease (1449)
Antibody-drug conjugate (ADC) (279)
Approvals (15938)
Artificial intelligence (504)
Autoimmune disease (155)
Automation (45)
Bankruptcy (279)
Best Places to Work (10382)
BIOSECURE Act (17)
Biosimilars (194)
Biotechnology (86)
Bladder cancer (150)
Brain cancer (48)
Breast cancer (560)
Cancer (4374)
Cardiovascular disease (365)
Career advice (1631)
Career pathing (32)
CAR-T (262)
CDC (38)
Celiac Disease (1)
Cell therapy (741)
Cervical cancer (37)
Clinical research (60716)
Collaboration (1722)
Company closure (3)
Compensation (662)
Complete response letters (49)
COVID-19 (2399)
CRISPR (88)
C-suite (760)
Cystic fibrosis (121)
Data (5837)
Decentralized trials (2)
Denatured (47)
Depression (123)
Diabetes (480)
Diagnostics (6453)
Digital health (41)
Diversity (7)
Diversity, equity & inclusion (34)
Drug discovery (250)
Drug pricing (169)
Drug shortages (31)
Duchenne muscular dystrophy (215)
Earnings (81246)
Editorial (54)
Employer branding (17)
Employer resources (123)
Events (97154)
Executive appointments (878)
FDA (18647)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (8)
Frontotemporal dementia (22)
Funding (1278)
Gene editing (183)
Generative AI (48)
Gene therapy (600)
GLP-1 (909)
Government (4207)
Grass and pollen (8)
Guidances (380)
Healthcare (15834)
HIV (59)
Huntington's disease (43)
IgA nephropathy (80)
Immunology and inflammation (205)
Immuno-oncology (56)
Indications (117)
Infectious disease (2650)
Inflammatory bowel disease (177)
Inflation Reduction Act (15)
Influenza (114)
Intellectual property (239)
Interviews (321)
IPO (14190)
IRA (45)
Job creations (3302)
Job search strategy (1360)
JPM (62)
Kidney cancer (15)
Labor market (64)
Layoffs (449)
Leadership (34)
Legal (7015)
Liver cancer (80)
Longevity (14)
Lung cancer (599)
Lymphoma (351)
Machine learning (36)
Management (54)
Manufacturing (859)
MASH (146)
Medical device (12826)
Medtech (12881)
Mergers & acquisitions (18364)
Metabolic disorders (1189)
mRNA (159)
Multiple sclerosis (141)
NASH (13)
Neurodegenerative disease (284)
Neuropsychiatric disorders (74)
Neuroscience (2560)
Neurotech (1)
NextGen: Class of 2026 (5454)
Non-profit (3507)
Now hiring (37)
Obesity (550)
Opinion (278)
Ovarian cancer (127)
Pain (179)
Pancreatic cancer (216)
Parkinson's disease (258)
Partnered (29)
Patents (479)
Patient recruitment (424)
Peanut (56)
People (51186)
Pharmaceutical (37)
Pharmacy benefit managers (25)
Phase 1 (18651)
Phase 2 (26352)
Phase 3 (20598)
Pipeline (5492)
Policy (262)
Postmarket research (2311)
Preclinical (7960)
Press Release (71)
Prostate cancer (239)
Psychedelics (38)
Radiopharmaceuticals (268)
Rare diseases (783)
Real estate (5576)
Recruiting (55)
Regulatory (23286)
Reports (38)
Research institute (2056)
Resumes & cover letters (279)
Rett syndrome (28)
RNA editing (16)
RSV (69)
Schizophrenia (138)
Series A (222)
Series B (149)
Service/supplier (8)
Sickle cell disease (93)
Special edition (20)
Spinal muscular atrophy (146)
Sponsored (40)
Startups (3108)
State (1)
Stomach cancer (13)
Supply chain (110)
Tariffs (87)
The Weekly (97)
Vaccines (898)
Venture capital (66)
Weight loss (364)
Women's health (82)
Worklife (18)
Date
Today (210)
Last 7 days (768)
Last 30 days (2579)
Last 365 days (26702)
2026 (4295)
2025 (26897)
2024 (31179)
2023 (35754)
2022 (46455)
2021 (50504)
2020 (49107)
2019 (41467)
2018 (31249)
2017 (30516)
2016 (29548)
2015 (34450)
2014 (27414)
2013 (23610)
2012 (25058)
2011 (25414)
2010 (23272)
Location
Africa (751)
Alabama (78)
Alaska (6)
Arizona (233)
Arkansas (13)
Asia (39661)
Australia (6490)
California (9767)
Canada (2968)
China (1098)
Colorado (447)
Connecticut (434)
Delaware (300)
Europe (86176)
Florida (1549)
Georgia (353)
Hawaii (3)
Idaho (51)
Illinois (833)
India (68)
Indiana (517)
Iowa (16)
Japan (429)
Kansas (115)
Kentucky (27)
Louisiana (22)
Maine (80)
Maryland (1306)
Massachusetts (7027)
Michigan (334)
Minnesota (497)
Mississippi (5)
Missouri (129)
Montana (30)
Nebraska (17)
Nevada (119)
New Hampshire (73)
New Jersey (2977)
New Mexico (28)
New York (2663)
North Carolina (1331)
North Dakota (9)
Northern California (4766)
Ohio (308)
Oklahoma (17)
Oregon (34)
Pennsylvania (2033)
Puerto Rico (22)
Rhode Island (42)
South America (1120)
South Carolina (66)
South Dakota (1)
Southern California (3868)
Tennessee (161)
Texas (1584)
United States (35906)
Utah (307)
Vermont (1)
Virginia (266)
Washington D.C. (63)
Washington State (795)
West Virginia (4)
Wisconsin (110)
Wyoming (2)
641,149 Results for "spectrum chemicals and laboratory products".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Model Medicines To Present Preclinical Data Readout for MDL-001, a Direct-Acting, Broad-Spectrum Antiviral Targeting a Novel Viral Mechanism, at IDWeek™ 2025
Data Presented At IDWeek 2025 To Demonstrate Broad-Spectrum Antiviral Activity And In Vivo Proof-of-Concept Across Both Respiratory And Liver Viruses
October 16, 2025
·
1 min read
Press Releases
Kraig Biocraft Laboratories Activates First Wave of 2026 Production Program
February 17, 2026
·
3 min read
Press Releases
Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
February 23, 2026
·
8 min read
Press Releases
Basilea and Prokaryotics enter collaboration to develop a novel broad-spectrum antifungal for the treatment of severe invasive infections
January 7, 2026
·
5 min read
Press Releases
NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza Wave - NV-387 is Effective Against H3N2
January 14, 2026
·
11 min read
Press Releases
Battelle Wins New Contract to Continue Environmental Research on Endocrine-disrupting Chemicals
February 24, 2026
·
2 min read
Press Releases
Jaguar Gene Therapy Announces Successful Completion of Dosing of First Patient Cohort in Clinical Trial Evaluating JAG201 for the Treatment of a Leading Monogenic Cause of Autism Spectrum Disorder Known as Phelan-McDermid Syndrome
February 24, 2026
·
11 min read
Press Releases
Thermo Fisher Scientific Expands Gibco™ Bacto™ Portfolio with Next-Generation, Chemically Defined Media to Boost E. coli Biomanufacturing Productivity
December 16, 2025
·
4 min read
Press Releases
1910 Publishes CANDID-CNS™, an AI Model That Unlocks Beyond Rule of 5 Chemical Space and Stereochemistry to Predict Blood–Brain Barrier Penetration
● CANDID-CNS™ is the new state-of-the-art AI model for BBB penetration: it achieves 87% AUPRC on bRo5 small molecules compared to 56% by Pfizer’s CNS MPO. ● CANDID-CNS™ distinguishes CNS penetrant stereoisomers at 68% compared to 50% by Pfizer’s CNS MPO. ● Published in the Journal of Chemical Information and Modeling, CANDID-CNS™ presents a breakthrough in AI Drug Discovery by unlocking the potential of bRo5 and stereochemistry to significantly expand the chemical space of small molecules that can be developed into CNS therapeutics.
December 4, 2025
·
1 min read
Press Releases
Ignite Biomedical and Liquid Biosciences Announce the Discovery of Biomarkers for the Diagnosis and Treatment of Autism Spectrum Disorder
November 5, 2025
·
6 min read
1 of 64,115
Next
